[AKRO] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
08-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -29.86%
YoY- -83.33%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 284 0 0 0 -
PBT -72,705 -55,987 -53,344 -55,186 -39,659 -31,083 -25,831 98.97%
Tax 0 0 -42 -12,527 8,732 6,260 -2,465 -
NP -72,705 -55,987 -53,344 -55,186 -39,659 -31,083 -23,366 112.69%
Tax Rate - - - - - - - -
Total Cost 72,705 55,987 53,344 55,470 39,659 31,083 23,366 112.69%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -19,431.69 0.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -1.05 -0.81 -0.90 -0.99 -0.71 -0.60 -0.50 63.76%
EPS Diluted -1.05 -0.81 -0.90 -0.99 -0.71 -0.60 -0.50 63.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.